A father of two from Nantwich, who was treated with proton beam therapy at The Christie in Manchester as part of a clinical trial, will share his experience with other patients at a high-profile conference in April.
Michael Schillinger, age 57, was diagnosed with head and neck cancer in 2020. He was referred to The Christie in September 2020 and became only the ninth adult patient to join the TORPEdO clinical trial.
The trial compares the impact of proton beam therapy with conventional radiotherapy for patients with oropharyngeal cancer.
As a result of his experience of being treated on trial with proton beam therapy, Michael has been invited to speak at a proton consumer day virtual conference on the afternoon of Friday, 28 April 2023.
The conference is open to anyone wanting to learn about proton therapy, particularly potential patients. Topics covered will include explaining how proton beam therapy works and why it benefits certain groups of patients, what it’s like to have proton treatment for children and adults, proton therapy research and clinical trials and a question-and-answer session with a panel of experts.
Anyone interested can register for the conference at:
Michael, who runs The Chilwell Arts Theatre in Nottingham, found a lump whilst shaving towards the end of July 2020. He wasn't sure if it was just a swollen gland, so he asked his GP. The GP was convinced it was cancer and made an urgent referral for tests, scans and a biopsy. The cancer diagnosis was confirmed on 20 August by a consultant at Leighton Hospital in Crewe, who believed it to be a stage 4 cancer, the most serious.
The father to Ben, age 16 and Kate, age 12, admits that the diagnosis was a frightening and traumatic life-changing event. "I remember thinking about my children, and it really hit me that they might have to grow up without a dad there to support them into adulthood", he said. "I wanted to keep things as normal as possible and didn't want them worrying. My wife Jackie was also extraordinary. She took on the entire responsibility for the family during that period.
“I was referred to Dr Price at The Christie in September. Meeting him helped to change my whole outlook on the diagnosis. Until then, I had felt out of control, but Dr Price explained everything and what it meant. He was the first person to give me hope, particularly when he told me that the cancer had been caused by HPV rather than lifestyle factors and was stage 3 rather than stage 4.
“He told me he was cautiously optimistic about a good outcome and asked if I wanted to join the TORPEdO clinical trial to use proton beam therapy rather than conventional radiotherapy. I immediately said yes, as my consultant at Leighton had already recommended that I should. Once I was accepted onto the TORPEdO trial my care transferred to Professor Thomson who was also very reassuring and gave me hope.”
Michael had two 18-hour chemotherapy infusions at The Christie and 33 proton beam treatment sessions. “I can’t imagine having a better experience anyway in the world”, said Michael. “The staff were remarkable, very attentive, and every detail had been thought about. It really felt like I was important to them. They even had someone I was able to discuss the psychological impact of the diagnosis with, which was very helpful.”
As Michael had head and neck cancer, he needed to wear a mask that fastened his head down to the treatment table, which he found uncomfortable but tolerable. He also struggled with swallowing because of the treatment. “The first two weeks after the proton treatment was the worst”, he said. “I was struggling to swallow, it was even hard to drink water, but I was determined not to have a feeding tube.”
Michael's uncle was diagnosed with less severe throat cancer five years before Michael but had a completely different experience as proton therapy was not an option then. "I am convinced that I’ve had a more positive treatment experience than my uncle”, said Michael.
"He had 22 teeth out before they could do the treatment. I only had one out. And he had even worse problems swallowing food and drink than me. The treatment affected my saliva glands, but I can now eat practically anything. I could even start eating curry again a year after my treatment, but he probably never will.”
Michael says he looks forward to participating in the proton consumer day conference. "I am pleased to have the opportunity to share my experiences with patients, the staff, and others interested in proton beam therapy. If a patient is considering joining a clinical trial, there is a big unknown. Hearing first-hand from other patients will give newly diagnosed patients the information they need and more options to consider.
“I think it is also valuable for the professionals involved in proton beam therapy to hear from patients, as it can help them improve an already excellent service.”
Following the head and neck cancer treatment, Michael had a further blow when a scan discovered an unrelated tumour on his kidney. The position of the tumour meant it was relatively straightforward for a surgeon to remove. Michael, who is an avid swimmer and film buff, has now made a full recovery. “I’m currently clear of cancer and expect to stay clear”, he said.
“My last check-up was in December 2022. The next one will be in December 2023. I will be monitored regularly for the first five years. The aftercare has been first-rate, and it is very reassuring to know that The Christie will keep an eye on me for the rest of my life.”
The proton consumer day on Friday, 28 April 2023 has been organised by The Christie, in conjunction with University College London Hospitals, CTRad, NCRI Radiotherapy Research Group and the Science and Technology Facilities Council.
Any patients interested in taking part in clinical trials should discuss this option with their consultant or GP. Not all patients will fit the criteria for a specific trial. While clinical trials can be successful for some patients, outcomes can vary from case to case.
About The Christie:
The Christie is a specialist cancer centre in Manchester and has more than 120 years of expertise in cancer care, research and education. It is one of Europe’s leading cancer centres, treating over 60,000 patients a year.
It is the largest provider of radiotherapy in the NHS (including high energy proton beam therapy and MR guided radiotherapy); it is home to the largest chemotherapy unit in the UK; and is a specialist surgical centre concentrating on rare cancers and complex procedures.
The Christie is one of Europe's largest experimental cancer medicine centres with around 650 clinical studies ongoing at any one time.
The Christie charity provides enhanced services for patients over and above what the NHS funds.
Visit www.christie.nhs.ukto find out more or follow The Christie on social media @TheChristieNHS.
A team from VINCI Building has raised more than £6,600 for Mid Cheshire Hospitals Charity after completing the legendary Fan Dance Challenge, one of the UK's toughest endurance events.
Two-way traffic will be reinstated on Winsford Station Bridge following further engineering assessments, with a 7.5 tonne weight restriction and 20mph speed limit being introduced to protect the structure.
A local grass roots apolitical action group, based in Macclesfield, who oppose the proposed Peak Cluster Pipeline are holding public events to help residents understand what this pipeline would entail.
Supporters joined The Wingate Centre’s team to celebrate the grand opening of Wingate Holidays, the Cheshire disability charity’s brand-new, fully accessible holiday accommodation in Wrenbury, near Nantwich.
Children and families across Cheshire are set to benefit from a major new approach to family justice designed to reduce delays, improve support for victims of domestic abuse, and ensure children's voices are heard throughout court proceedings.
Stoptober is the Department of Health & Social Care’s annual quit smoking campaign, designed to encourage and support people who smoke to make a quit attempt.
New crossings, cycleway improvements and enhanced walking routes will be delivered as part of phase 2 of the Manchester Road Active Travel scheme, with construction due to begin on Monday 5th October.
For the Community is preparing for its 11th Christmas supporting people across Buxton and the surrounding area, continuing a project that began with one simple idea: nobody should have to face Christmas without food, company or community.
Rail campaigners will gather at Congleton Station at 11am on Sunday 20th September to mark a frustrating milestone – two years since the last Sunday train stopped at Congleton.
Cheshire East Council visited Need Golf Centre as part of its Made in Cheshire East campaign, highlighting the businesses and organisations helping to drive economic growth, attract visitors and strengthen the borough's reputation as a place to live, work, invest and do business.
Comments
Add a comment